Others have showed that ECD knockdown reduced cell growth, proliferation and tumorigenicity in vivo while affecting glucose uptake by pancreatic cancer cells and reduced phosphorylation of Akt [43]. The gene discussed is ECD; the disease is pancreatic neoplasm.